-
1
-
-
33846786928
-
Health and Osteoporosis
-
U.S. Public Health Services. Department of Health and Human Services. Available at
-
Bone Health and Osteoporosis: a Report of the Surgeon General U.S. Public Health Services. Department of Health and Human Services. Available at: http://www.hhs.gov/surgeongeneral/library/bonehealth/docs/full_report.pdf
-
a Report of the Surgeon General
-
-
Bone1
-
2
-
-
33744977921
-
Meta-analysis: Accuracy of quantitative ultrasound for identifying patients with osteoporosis
-
Nayak S, Ingram O, Liu H, et al. Meta-analysis: accuracy of quantitative ultrasound for identifying patients with osteoporosis. Ann Intern Med. 2006;144: 832-841.
-
(2006)
Ann Intern Med
, vol.144
, pp. 832-841
-
-
Nayak, S.1
Ingram, O.2
Liu, H.3
-
3
-
-
12144289279
-
Ten years' experience with alendronate for osteoporosis in postmenopausal women
-
Bone JG, Hosking D, Jean-Pierre D, et al. Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med. 2004;350:1189-1199.
-
(2004)
N Engl J Med
, vol.350
, pp. 1189-1199
-
-
Bone, J.G.1
Hosking, D.2
Jean-Pierre, D.3
-
5
-
-
18744369929
-
Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomized Evaluation of Calcium Or vitamin D, RECORD): A randomized placebo-controlled trial
-
Grant AM, Avenell A, Campbell MK, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomized Evaluation of Calcium Or vitamin D, RECORD): a randomized placebo-controlled trial. Lancet. 2005;365:1621-1628.
-
(2005)
Lancet
, vol.365
, pp. 1621-1628
-
-
Grant, A.M.1
Avenell, A.2
Campbell, M.K.3
-
6
-
-
0141705375
-
Effects of estrogen plus progestin on risk of fracture and bone mineral density: The Women's Health Initiative randomized trial
-
Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA. 2003;290:1729-1738.
-
(2003)
JAMA
, vol.290
, pp. 1729-1738
-
-
Cauley, J.A.1
Robbins, J.2
Chen, Z.3
-
7
-
-
0037014630
-
Noncadiovascular disease outcomes during 6.8 years of hormone therapy: Heart and estrogen/progestin
-
Hulley S, Furber C, Barrett-Connor E, et al. Noncadiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin. JAMA. 2002;288:58-66.
-
(2002)
JAMA
, vol.288
, pp. 58-66
-
-
Hulley, S.1
Furber, C.2
Barrett-Connor, E.3
-
8
-
-
18544381541
-
Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial
-
Delmas PD, Ensrud KE, Adachi JD, et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab. 2002;87: 3609-3617.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 3609-3617
-
-
Delmas, P.D.1
Ensrud, K.E.2
Adachi, J.D.3
-
9
-
-
0033829969
-
Arandomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The Prevent Recurrence of Osteoporotic Fractures study
-
Chesnut CH III, Silverman S, Andriano K, et al.Arandomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent Recurrence of Osteoporotic Fractures study. Am J Med. 2000;109:267-276.
-
(2000)
Am J Med
, vol.109
, pp. 267-276
-
-
Chesnut III, C.H.1
Silverman, S.2
Andriano, K.3
-
10
-
-
4544262219
-
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis
-
Chesnut CH III, Skag A, Christiansen C, et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res. 2004;19:1241-1249.
-
(2004)
J Bone Miner Res
, vol.19
, pp. 1241-1249
-
-
Chesnut III, C.H.1
Skag, A.2
Christiansen, C.3
-
11
-
-
0033552255
-
Effects of risedronate treatment on vertebral and nonvertebral fractures in womenwith postmenopausal osteoporosis. A Randomized Controlled Trial
-
Harris ST, Watts NB, Genant FK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in womenwith postmenopausal osteoporosis. A Randomized Controlled Trial. JAMA. 1999;282:1344-1352.
-
(1999)
JAMA
, vol.282
, pp. 1344-1352
-
-
Harris, S.T.1
Watts, N.B.2
Genant, F.K.3
-
12
-
-
33646836925
-
Systematic review: Bisphosphates and osteonecrosis of the jaws
-
Woo S, Hellstein J, Kalmar J. Systematic review: bisphosphates and osteonecrosis of the jaws. Ann Intern Med. 2006;144:753-761.
-
(2006)
Ann Intern Med
, vol.144
, pp. 753-761
-
-
Woo, S.1
Hellstein, J.2
Kalmar, J.3
-
13
-
-
0035837553
-
Effect of parathyroid hormone (1 to 34) on fractures and bone mineral density in postmenopausal women with osteoporosis
-
Neer RM, Arnaud C, Zanchetta JR, et al. Effect of parathyroid hormone (1 to 34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344: 1434-1441.
-
(2001)
N Engl J Med
, vol.344
, pp. 1434-1441
-
-
Neer, R.M.1
Arnaud, C.2
Zanchetta, J.R.3
-
14
-
-
29044449457
-
Reduction of pain and fracture incidence after kyphoplasty: 1-year outcomes of a prospective controlled trial of patients with primary osteoporosis
-
Grafe IA, Da Fonseca K, Hillmeier J, et al. Reduction of pain and fracture incidence after kyphoplasty: 1-year outcomes of a prospective controlled trial of patients with primary osteoporosis. Osteoporosis Int. 2005;16:2005-2012.
-
(2005)
Osteoporosis Int
, vol.16
, pp. 2005-2012
-
-
Grafe, I.A.1
Da Fonseca, K.2
Hillmeier, J.3
-
16
-
-
0036048481
-
Exercise for preventing and treating osteoporosis in postmenopausal women (Review)
-
DOI: 10.1002/14651858.CD000333
-
Bonaiuti D, Shea B, Lovine R, et al. Exercise for preventing and treating osteoporosis in postmenopausal women (Review). Cochrane Database Syst Rev. 2002. DOI: 10.1002/14651858.CD000333.
-
(2002)
Cochrane Database Syst Rev
-
-
Bonaiuti, D.1
Shea, B.2
Lovine, R.3
-
18
-
-
0037150130
-
Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial
-
Greenspan SL, Schneider DL, McClung MR, et al. Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2002;136:742.
-
(2002)
Ann Intern Med
, vol.136
, pp. 742
-
-
Greenspan, S.L.1
Schneider, D.L.2
McClung, M.R.3
-
19
-
-
0035253489
-
Effect of risedronate on the risk of hip fracture in elderly women
-
McClung M, Geusens P, Miller P, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med. 2001;44:333-340.
-
(2001)
N Engl J Med
, vol.44
, pp. 333-340
-
-
McClung, M.1
Geusens, P.2
Miller, P.3
|